Things You Need To Know About Erectile Dysfunction

Sildenafil may be available through a mail-order pharmacy. Using this type of service may help lower the drug’s cost and allow you to receive your medication without leaving home.

• Cheap sildenafil is often sourced from unregulated markets.
• Verify authenticity before purchasing low-cost options.
• Higher prices may indicate higher quality and safety.
• Online reviews help assess pharmacy reliability and prices.

Some Medicare plans may help cover the cost of mail-order medications.

How to get Sildenafil from Us?

Restricted access may deter additional opportunities for discovery and innovation. If not for the widespread coverage of low-cost dexamethasone for multiple indications, its lifesaving potential in COVID-19 patients may not been realized. As we strive to create a new normal post COVID-19, the reassessment of previously considered low-value services provides an appealing framework of how we might reallocate medical care spending to optimize population health. While ED may not be considered a high priority chronic condition, the negative impact on the quality of life of men and their partners will likely become more prevalent due to COVID-19. Given recent dramatic price reductions for generic formulations, the well-established clinical benefits of ED treatments should be reconsidered by payers.

Check Pharmacy Prices

The resultant improvements in patient-centered outcomes from better access to these high-value services will be heightened further by the integration of telemedicine, positive impact on continuity of care, and the potential for future innovation. You may also be able to get a 90-day supply of the drug via mail order. If you do not have health insurance, talk with your doctor or pharmacist. They may be able to suggest online pharmacy options that could work for you. If you need financial support to pay for sildenafil, consider looking into websites that offer cost resources and information. These sites can provide details on drug assistance programs, ways to make the most of your insurance coverage, and links to savings cards and other services.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Viagra Generic	150mg	10 Pills	36.73€ 34.98€	Buy
Kamagra Soft Tabs	100mg	180 + 8 Pills	425.45€ 405.19€	Buy
Viagra Generic	50mg	120 + 6 Pills	129.64€ 123.47€	Buy
Kamagra Polo	100mg	84 + 4 Pills	244.49€ 232.85€	Buy
Viagra Generic	100mg	270 + 10 Pills	270.47€ 257.59€	Buy
Kamagra	100mg	60 + 4 Pills	201.34€ 191.75€	Buy
Kamagra Oral Jelly	100mg	30 + 5 Sachets	136.20€ 129.71€	Buy
Kamagra Oral Jelly	100mg	90 + 8 Sachets	303.56€ 289.10€	Buy
Kamagra	100mg	32 Pills	121.24€ 115.47€	Buy
Viagra Generic	200mg	270 + 10 Pills	379.76€ 361.68€	Buy
Kamagra Polo	100mg	120 + 6 Pills	327.15€ 311.57€	Buy
Viagra Generic	150mg	270 + 10 Pills	326.61€ 311.06€	Buy
Kamagra Polo	100mg	272 + 12 Pills	622.94€ 593.28€	Buy
Viagra Generic	50mg	30 + 4 Pills	54.26€ 51.68€	Buy
Viagra Generic	100mg	20 Pills	45.58€ 43.41€	Buy

Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date.

Patient Assistance & Copay Programs for Sildenafil

Sildenafil may be available through a mail-order pharmacy. Using this type of service may help lower the drug’s cost and allow you to receive your medication without leaving home. Some Medicare plans may help cover the cost of mail-order medications. You may also be able to get a 90-day supply of the drug via mail order. If you do not have health insurance, talk with your doctor or pharmacist.

RxSaver Editors

They may be able to suggest online pharmacy options that could work for you. If you need financial support to pay for sildenafil, consider looking into websites that offer cost resources and information. These sites can provide details on drug assistance programs, ways to make the most of your insurance coverage, and links to savings cards and other services. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or other healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

• Bulk purchasing can reduce sildenafil costs per pill.
• Insurance usually does not cover sildenafil unless prescribed for certain conditions.
• Discount programs and coupons can lower the overall price.
• Local price variations depend on pharmacy policies and region.

The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Optum Perks is owned by RVO Health. By clicking on this link, we may receive a commission.

Frequently Asked Questions

The coronavirus disease 2019 (COVID-19) pandemic caused dramatic reductions in clinically indicated care, but also cut services that produced little or no benefit to patients. As we establish a value-based “new normal” post-COVID-19, the clinical community should leverage this opportunity to enhance the efficiency of the delivery system by investing more resources in those services that improve patient-centered outcomes, while deterring a resurgence of low-value care.1 This reset provides an opportunity to reassess and reprioritize services that were previously determined as high and low value. A fresh look at the clinical and economic implications of the management of erectile dysfunction (ED) can serve as an intriguing example of how we might attain a more value-driven system.

Year	Average Price per Tablet	Notable Market Changes	Comments
2018	$10	Entry of generics increased competition	Stable pricing
2019	$10.5	Slight price hike due to manufacturing costs	Slight increase
2020	$9.8	Pandemic effects disrupted supply	Slight decrease
2021	$11	New brand launches, marketing surge	Price bump
2022	$11.5	Increased raw material costs	Price climbing
2023	$12	Continued inflation and demand	Steady rise

While certainly not at the forefront of the pandemic, the long-term clinical consequences of COVID-19-related illness will likely extend to men's sexual health.2 There is growing evidence to support that COVID-19 targets endothelium.3 , 4 Erectile dysfunction often results from endothelial dysfunction—early data suggest that COVID-19 remains present in penile tissue long after infection with COVID-19 and widespread endothelial dysfunction may be a major contributing factor to ED in COVID-19 survivors.2 , 5 , 6 A potential increase in ED incidence,5 coupled with the spectacular (>8000%) growth of telemedicine, is likely to create a ‘perfect storm’ of new demand for ED care. Although highly effective ED treatments exist, a lack of coverage for ED medications by public and private payers’ limits utilization.7, 8, 9 In a 2000 Health Affairs commentary, “The Economics of Viagra,” Alison Keith explained that the main rationale used by US payers to avoid coverage was that Viagra was not a “medical treatment,” but rather a “lifestyle enhancement” outside the realm of insurance contract.10 Given the increased clinical knowledge of ED which supports its’ use as a medical treatment and an improved value proposition ushered by a substantial decrease in ED drug pricing, a reassessment of coverage for ED medications and sexual medicine specialist consultations is warranted by health plans and public payers. The primary objective of this reassessment of coverage would be to enhance access to this high-value service and reduce the fragmented delivery of care provided by independent vendors that disrupts continuity of care. The rising costs of branded and specialty sildenafil price ireland prescription drugs are a top policy concern in the United States. Despite the widespread attention to a small number of extremely expensive medications, little consideration is paid to situations when drug prices decrease. Over the last decade, sildenafil, a first-line ED treatment, experienced a drastic price reduction from a peak of $88.45 per pill for the branded version (Viagra 100 mg),11 , 12 to $1-$4 a pill for a generic version. A 2000 article in Annals of Internal Medicine reported that branded Viagra was cost-effective compared to other commonly used clinical interventions.13 There is little doubt therefore, that the lower cost, higher value, generic version of Viagra represents an even more cost-effective intervention. ED services are of high value by virtue of their effectiveness, population-wide health impact, low price, and cost-effectiveness.14 , 15 Higher value, lower priced ED drugs couples well with the COVID-19 driven growth of telemedicine.

Factor	Description	Typical Impact
Brand Reputation	Well-known brands typically charge higher prices	Increases prices
Dosage Strength	Higher dosages tend to cost more	Upward trend
Packaging Size	Larger packs often reduce per-tablet cost	Price reduction
Market Regulations	Strict approval processes can increase production costs	Higher prices
Generic Availability	Generics usually lower prices	Price decrease

Unlike many clinical conditions that require in-person evaluation, many ED patients are not required to have a physical presence at a clinician's office. This feature was a driving force behind the growth of independent, online men's health companies, which typically sell generic sildenafil at exorbitant prices. This current ‘carved out’ model of ED management disrupts continuity of care, the deterioration of which has been demonstrated to worsen patient satisfaction and clinical outcomes. Individuals with ED have an increased risk of cardiovascular disease, coronary heart disease, stroke, and all-cause mortality.16 In addition to physical health, treatment of ED has been associated with improved psychological health (eg, anxiety, depression), which was especially notable during the period of COVID-19 lockdown.17 Online men's health companies who offer ED treatment often provide limited evaluations and lack continuity of care; the fragmentation of care is a missed opportunity for a healthcare provider to evaluate a patients’ overall health and evaluate for life-threatening comorbidities.18 Diagnosis and treatment of ED and appropriate early optimization of other cardiovascular risk factors can improve overall health and life expectancy.19 In addition, treatment of ED may promote overall general health and avoidance of risky behaviors through consultation with a provider or sexual medicine specialist who would promote a healthy lifestyle and harm reduction.20 In the current system, the lack of coverage for sildenafil and other phosphodiesterase-5 inhibitors (eg, tadalafil) may effectively deter patients from engaging in routine doctor visits; this may have longstanding detrimental effects. With the recent rapid adoption of telehealth into routine practice, primary care and specialty providers can now offer the same convenience/discretion as online men's health vendors to patients as independent vendors. The added benefit is a relationship with a healthcare provider and continuity of care. Moreover, telehealth has been shown to be effective for patients with ED.21 Though previously perceived by many payers as a low-value commodity, the decrease in sildenafil pricing (and correlated over 10-fold increase in value) presents an opportunity for public and private payers to reassess coverage decisions. This is of particular importance to Medicare and Employer-Sponsored prescription drug plans, many of which currently do not cover generic sildenafil.22, 23, 24, 25 This transition would lead to an improved care delivery model with substantial benefits, including a significant ‘spillover effect’ of increased continuity of care. A stable clinician-patient relationship would better facilitate the management of hypertension, diabetes, cardiovascular disease, and cerebrovascular disease, all closely associated with ED. In addition, reducing fragmentation will likely lead to a reduction in drug to drug interactions (often seen in the Direct To Consumer (DTC) setting),26 decreased counterfeit distribution, enhanced preventive care utilization, and increased patient satisfaction.

Stronger erections, better sex

Counterfeit distribution of phosphodiesterase-5 inhibitors, which may have contaminants and is often done without consultation with a physician or sexual medicine specialist—this may seriously endanger patients.27 The enhanced availability of generic drugs can produce important incremental long-term benefits to the population at large. During the COVID-19 pandemic, generic medicines, most notably the steroid drugs that have significantly reduced the risk of death in COVID-19 patients, have proven themselves to truly be the bridge to a vaccine. Viagra was developed after participants in an early trial assessing sildenafil's potential as an antihypertensive, experienced potent erections as a side effect.

Start your treatment journey

With the recent rapid adoption of telehealth into routine practice, primary care and specialty providers can now offer the same convenience/discretion as online men's health vendors to patients as independent vendors. The added benefit is a relationship with a healthcare provider and continuity of care. Moreover, telehealth has been shown to be effective for patients with ED.21 Though previously perceived by many payers as a low-value commodity, the decrease in sildenafil pricing (and correlated over 10-fold increase in value) presents an opportunity for public and private payers to reassess coverage decisions. This is of particular importance to Medicare and Employer-Sponsored prescription drug plans, many of which currently do not cover generic sildenafil.22, 23, 24, 25 This transition would lead to an improved care delivery model with substantial benefits, including a significant ‘spillover effect’ of increased continuity of care. A stable clinician-patient relationship would better facilitate the management of hypertension, diabetes, cardiovascular disease, and cerebrovascular disease, all closely associated with ED.

Your expert team

In addition, reducing fragmentation will likely lead to a reduction in drug to drug interactions (often seen in the Direct To Consumer (DTC) setting),26 decreased counterfeit distribution, enhanced preventive care utilization, and increased patient satisfaction. Counterfeit distribution of phosphodiesterase-5 inhibitors, which may have contaminants and is often done without consultation with a physician or sexual medicine specialist—this may seriously endanger patients.27 The enhanced availability of generic drugs can produce important incremental long-term benefits to the population at large. During the COVID-19 pandemic, generic medicines, most notably the steroid drugs that have significantly reduced the risk of death in COVID-19 patients, have proven themselves to truly be the bridge to a vaccine. Viagra was developed after participants in an early trial assessing sildenafil's potential as an antihypertensive, experienced potent erections as a side effect. Its widespread use for ED led to its development as an effective agent for pulmonary hypertension. Its widespread use for ED led to its development as an effective agent for pulmonary hypertension. Restricted access may deter additional opportunities for discovery and innovation. If not for the widespread coverage of low-cost dexamethasone for multiple indications, its lifesaving potential in COVID-19 patients may not been realized. As we strive to create a new normal post COVID-19, the reassessment of previously considered low-value services provides an appealing framework of how we might reallocate medical care spending to optimize population health. While ED may not be considered a high priority chronic condition, the negative impact on the quality of life of men and their partners will likely become more prevalent due to COVID-19.

Stay on track with Rx alerts & expert care

The primary objective of this reassessment of coverage would be to enhance access to this high-value service and reduce the fragmented delivery of care provided by independent vendors that disrupts continuity of care. The rising costs of branded and specialty sildenafil price ireland prescription drugs are a top policy concern in the United States. Despite the widespread attention to a small number of extremely expensive medications, little consideration is paid to situations when drug prices decrease. Over the last decade, sildenafil, a first-line ED treatment, experienced a drastic price reduction from a peak of $88.45 per pill for the branded version (Viagra 100 mg),11 , 12 to $1-$4 a pill for a generic version. A 2000 article in Annals of Internal Medicine reported that branded Viagra was cost-effective compared to other commonly used clinical interventions.13 There is little doubt therefore, that the lower cost, higher value, generic version of Viagra represents an even more cost-effective intervention.

How to get Viagra

ED services are of high value by virtue of their effectiveness, population-wide health impact, low price, and cost-effectiveness.14 , 15 Higher value, lower priced ED drugs couples well with the COVID-19 driven growth of telemedicine. Unlike many clinical conditions that require in-person evaluation, many ED patients are not required to have a physical presence at a clinician's office. This feature was a driving force behind the growth of independent, online men's health companies, which typically sell generic sildenafil at exorbitant prices. This current ‘carved out’ model of ED management disrupts continuity of care, the deterioration of which has been demonstrated to worsen patient satisfaction and clinical outcomes. Individuals with ED have an increased risk of cardiovascular disease, coronary heart disease, stroke, and all-cause mortality.16 In addition to physical health, treatment of ED has been associated with improved psychological health (eg, anxiety, depression), which was especially notable during the period of COVID-19 lockdown.17 Online men's health companies who offer ED treatment often provide limited evaluations and lack continuity of care; the fragmentation of care is a missed opportunity for a healthcare provider to evaluate a patients’ overall health and evaluate for life-threatening comorbidities.18 Diagnosis and treatment of ED and appropriate early optimization of other cardiovascular risk factors can improve overall health and life expectancy.19 In addition, treatment of ED may promote overall general health and avoidance of risky behaviors through consultation with a provider or sexual medicine specialist who would promote a healthy lifestyle and harm reduction.20 In the current system, the lack of coverage for sildenafil and other phosphodiesterase-5 inhibitors (eg, tadalafil) may effectively deter patients from engaging in routine doctor visits; this may have longstanding detrimental effects. Given recent dramatic price reductions for generic formulations, the well-established clinical benefits of ED treatments should be reconsidered by payers. The resultant improvements in patient-centered outcomes from better access to these high-value services will be heightened further by the integration of telemedicine, positive impact on continuity of care, and the potential for future innovation.

Potential Side Effects and Safety Measures

You should always consult your doctor or other healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Optum Perks is owned by RVO Health. By clicking on this link, we may receive a commission.

Getting a 3-month supply

The coronavirus disease 2019 (COVID-19) pandemic caused dramatic reductions in clinically indicated care, but also cut services that produced little or no benefit to patients. As we establish a value-based “new normal” post-COVID-19, the clinical community should leverage this opportunity to enhance the efficiency of the delivery system by investing more resources in those services that improve patient-centered outcomes, while deterring a resurgence of low-value care.1 This reset provides an opportunity to reassess and reprioritize services that were previously determined as high and low value. A fresh look at the clinical and economic implications of the management of erectile dysfunction (ED) can serve as an intriguing example of how we might attain a more value-driven system. While certainly not at the forefront of the pandemic, the long-term clinical consequences of COVID-19-related illness will likely extend to men's sexual health.2 There is growing evidence to support that COVID-19 targets endothelium.3 , 4 Erectile dysfunction often results from endothelial dysfunction—early data suggest that COVID-19 remains present in penile tissue long after infection with COVID-19 and widespread endothelial dysfunction may be a major contributing factor to ED in COVID-19 survivors.2 , 5 , 6 A potential increase in ED incidence,5 coupled with the spectacular (>8000%) growth of telemedicine, is likely to create a ‘perfect storm’ of new demand for ED care. Although highly effective ED treatments exist, a lack of coverage for ED medications by public and private payers’ limits utilization.7, 8, 9 In a 2000 Health Affairs commentary, “The Economics of Viagra,” Alison Keith explained that the main rationale used by US payers to avoid coverage was that Viagra was not a “medical treatment,” but rather a “lifestyle enhancement” outside the realm of insurance contract.10 Given the increased clinical knowledge of ED which supports its’ use as a medical treatment and an improved value proposition ushered by a substantial decrease in ED drug pricing, a reassessment of coverage for ED medications and sexual medicine specialist consultations is warranted by health plans and public payers.